Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Treatment of acute cryptococcal meningitis in HIV infected adults, with an emphasis on resource-limited settings.

Sloan D, Dlamini S, Paul N, Dedicoat M.

Cochrane Database Syst Rev. 2008 Oct 8;(4):CD005647. doi: 10.1002/14651858.CD005647.pub2. Review.

PMID:
18843697
2.

Comparison of flucytosine and fluconazole combined with amphotericin B for the treatment of HIV-associated cryptococcal meningitis: a systematic review and meta-analysis.

Yao ZW, Lu X, Shen C, Lin DF.

Eur J Clin Microbiol Infect Dis. 2014 Aug;33(8):1339-44. doi: 10.1007/s10096-014-2074-2. Review.

PMID:
24550039
3.

Interventions for the prevention and management of oropharyngeal candidiasis associated with HIV infection in adults and children.

Pienaar ED, Young T, Holmes H.

Cochrane Database Syst Rev. 2010 Nov 10;(11):CD003940. doi: 10.1002/14651858.CD003940.pub3. Review.

PMID:
21069679
4.
5.

Cryptococcal meningitis.

Bicanic T, Harrison TS.

Br Med Bull. 2005 Apr 18;72:99-118. Review.

PMID:
15838017
6.

Flucytosine and cryptococcosis: time to urgently address the worldwide accessibility of a 50-year-old antifungal.

Loyse A, Dromer F, Day J, Lortholary O, Harrison TS.

J Antimicrob Chemother. 2013 Nov;68(11):2435-44. doi: 10.1093/jac/dkt221. Review.

7.

Therapy for cryptococcal meningitis in patients with AIDS.

Powderly WG.

Clin Infect Dis. 1992 Mar;14 Suppl 1:S54-9. Review.

PMID:
1562696
8.

Antifungal interventions for the primary prevention of cryptococcal disease in adults with HIV.

Chang LW, Phipps WT, Kennedy GE, Rutherford GW.

Cochrane Database Syst Rev. 2005 Jul 20;(3):CD004773. Review.

PMID:
16034947
9.

The management of cryptococcal meningitis in Papua New Guinea.

Seaton RA.

P N G Med J. 1996 Mar;39(1):67-73. Review.

PMID:
9522853
10.

Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections.

Moen MD, Lyseng-Williamson KA, Scott LJ.

Drugs. 2009;69(3):361-92. doi: 10.2165/00003495-200969030-00010. Review.

PMID:
19275278
11.

Cryptococcal meningitis in patients with the acquired immunodeficiency syndrome.

Zeind CS, Cleveland KO, Menon M, Brown JR, Solomon DK.

Pharmacotherapy. 1996 Jul-Aug;16(4):547-61. Review.

PMID:
8840361
12.

Treatment of cryptococcal meningitis in resource limited settings.

Sloan DJ, Dedicoat MJ, Lalloo DG.

Curr Opin Infect Dis. 2009 Oct;22(5):455-63. doi: 10.1097/QCO.0b013e32832fa214. Review.

13.

[Cryptococcal meningitis].

van Spil WE, Nooijen S, de Jong PY, Aliredjo RP, de Sévaux RG, Verhave JC.

Ned Tijdschr Geneeskd. 2015;159:A8478. Review. Dutch.

PMID:
25827149
14.

Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.

Siegfried N, van der Merwe L, Brocklehurst P, Sint TT.

Cochrane Database Syst Rev. 2011 Jul 6;(7):CD003510. doi: 10.1002/14651858.CD003510.pub3. Review.

PMID:
21735394
15.

[The efficacy of sequential treatment with amphotericin B-fluorocytosine and fluconazole in cryptococcal meningitis not associated with AIDS].

Pintado García V, Martín Dávila P, Muñoz Labián V, Quereda Rodríguez-Navarro C.

Rev Clin Esp. 1999 Jul;199(7):480. Review. Spanish. No abstract available.

PMID:
10481571
16.

Management of toxoplasmic encephalitis in HIV-infected adults (with an emphasis on resource-poor settings).

Dedicoat M, Livesley N.

Cochrane Database Syst Rev. 2006 Jul 19;(3):CD005420. Review.

PMID:
16856096
17.

New insights in the prevention, diagnosis, and treatment of cryptococcal meningitis.

Jackson A, van der Horst C.

Curr HIV/AIDS Rep. 2012 Sep;9(3):267-77. doi: 10.1007/s11904-012-0127-7. Review.

PMID:
22763808
18.

Overview: treatment of cryptococcal meningitis.

Sugar AM, Stern JJ, Dupont B.

Rev Infect Dis. 1990 Mar-Apr;12 Suppl 3:S338-48. Review.

PMID:
2184512
19.

Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.

Volmink J, Siegfried NL, van der Merwe L, Brocklehurst P.

Cochrane Database Syst Rev. 2007 Jan 24;(1):CD003510. Review. Update in: Cochrane Database Syst Rev. 2011;(7):CD003510.

PMID:
17253490
20.

Optimal monitoring strategies for guiding when to switch first-line antiretroviral therapy regimens for treatment failure in adults and adolescents living with HIV in low-resource settings.

Chang LW, Harris J, Humphreys E.

Cochrane Database Syst Rev. 2010 Apr 14;(4):CD008494. doi: 10.1002/14651858.CD008494. Review.

PMID:
20393969
Items per page

Supplemental Content

Support Center